الفهرس 
Formulation and Evaluation of Dapoxetine Hydrochloride-Loaded Transethosome Nanovesicles Hydrogel for Treatment of Rheumatoid Arthritis via Transdermal DeliveryOnly 14 pages are availabe for public view
 |  | from | 421 |  |  |
| | | from | 421 | | |
Abstract
Purpose: Dapoxetine Hcl (DH), A selective Serotonin Reuptake Inhibitor, May Be Useful For The Treatment Of Rheumatic Arthritis (RA). The Purpose Of This Study Was To Investigate The Therapeutic Efficacy Of Transdermal Delivery Of DH In Transethosome Nanovesicles (Tenvs). This Novel Delivery Of DH May Overcome The Drawbacks Associated With Orally Administered DH And Improve Patient Compliance.
Methods: DH-TENV Formulations Were Prepared Using An Injection- Sonication Method And Optimized Using A 33 Box-Behnken-Design With Design Expert® Software. The TENV Formulations Were Assessed For Entrapment Efficiency (EE-%), Vesicle Size, Zeta Potential, In Vitro DH Release, And Skin Permeation. The Optimized Tenvs And Plain DH Were Incorporated Into Three Different Hydrogel Matrices Including Carbopol 971P, HPMC K15M And Chitosan. The Tolerability Of The Optimized DH-TENV Gel Was Investigated Using A Rat Skin Irritation Test. A Pharmacokinetic Analysis Of The Optimized DH-TENV Gel Was Also Conducted In Rats. Moreover, The Anti-RA Activity Of The Optimized DH-TENV Gel Was Assessed Based On The RA-Specific Marker Anti-Cyclic Cirtullinated Peptide Antibody (Anti-CCP), The Cartilage Destruction Marker Cartilage Oligomeric Matrix Protein (COMP) And The Inflammatory Marker Interleukin-6 (IL-6). Level Of Tissue Receptor Activator Of Nuclear Factor Kappa-Β Ligand (RANKL) Were Also Assessed.
Results: The Optimized DH-TENV Formulation Involved Spherical Nanovesicles That Had An Appropriate EE- % And Skin Permeation characteristics. The DH-TENV Gel Was Well Tolerated By Rats. The Pharmacokinetics Analysis Showed That The Optimized DH-TENV Gel Boosted The Bioavailability Of The DH By 2.42- And 4.16-Fold Compared To The Oral DH Solution And The Control DH Gel, Respectively. Moreover, It Significantly Reduced The Serum Anti-CCP, COMP And IL-6 Levels And Decreased The RANKL Levels. Furthermore, The DH-TENV Gel Attenuated Histopathological Changes By Almost Normalizing The Articular Surface And Synovial Fluid.
Conclusion: The Results Indicate That DH-Tenvs Can Improve Transdermal Delivery Of DH And Thereby Alleviate RA.
Keywords: Dapoxetine Hydrochloride; Transethosome Nanovesicles; Rheumatoid Arthritis; Transdermal Delivery; Pharmacokinetic Study, RANKL.